Manuscript

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Posted on

AUTHORS: Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, Chau I, Ernstoff MS, Gardner JM, Ginex P, Hallmeyer S, Holter Chakrabarty J, Leighl NB, Mammen JS, McDermott DF, Naing A, Nastoupil LJ, Phillips T, Porter LD, Puzanov I, Reichner CA, Santomasso BD, Seigel C, Spira A, Suarez-Almazor ME, Wang Y, Weber […]

Poster

Comparative Efficacy Of Consolidation Therapy After Chemoradiation Therapy (Crt) In Patients With Unresectable, Stage Iii Non-Small Cell Lung Cancer (Nsclc): A Network Meta-Analysis

Posted on

AUTHORS: Husain F., Harari O., Fazeli M., Zhang Y. CONFERENCE: ISPOR 2018 DATE: May 19-23, 2018. Objectives: This study aims to estimate the comparative clinical efficacy of consolidation therapies after cCRT, by using network meta-analysis (NMA). This current analysis focuses on progression free survival (PFS). See poster 2018-ISPOR-AstraZeneca-Poster

Poster

Term Indexing Technology to Support the Feasibility Assessment of a Benefit-Risk Network Meta-Analysis.

Posted on

AUTHORS: Snyder S., Bhattacharya M., Hendrickson B, Butylkova K, Lievano F; Scarzzini L, CONFERENCE: DIA Annual Meeting 2017 DATE: June 18-22, 2017. Objective: Perform a BRA of interventions across two therapeutic classes using a NMA approach Use term-indexing technology to improve synonym management, feasibility assessment, and outcome selection for NMA 2017-DIA-DRE-Abbvie-NMA-Poster See poster